Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Matthew Allen Schiffler"'
Autor:
Boris A. Czeskis, Bryan H. Norman, Norman Earle Hughes, Kenneth C. Cassidy, Kuklish Steven Lee, Debra Luffer-Atlas, Matthew Fisher, Trent L. Abraham, Matthew Allen Schiffler, Jeffrey J. Alberts
Publikováno v:
Journal of Medicinal Chemistry. 61:2041-2051
Two 2-aminoimidazole-based inhibitors, LY3031207 (1) and LY3023703 (2), of the microsomal prostaglandin E synthase-1 (mPGES-1) enzyme were found to cause drug-induced liver injury (DILI) in humans. We studied imidazole ring substitutions to successfu
Autor:
J.L. Oskins, Bryan H. Norman, Mark Chambers, Norman Earle Hughes, Stefan Jon Thibodeaux, Matthew Allen Schiffler, Matthew J. Fisher, Thomas W. Seng, Xiao-Peng Yu, C. Lin, Srinivasan Chandrasekhar, Anita K. Harvey
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 356:635-644
Prostaglandin (PG) E2 plays a critical role in eliciting inflammation. Nonsteroidal anti-inflammatory drugs and selective inhibitors of cyclooxygenase, which block PGE2 production, have been used as key agents in treating inflammation and pain associ
Autor:
Srinivasan Chandrasekhar, Tatiana Natali Vetman, Xushan Wang, Anita K. Harvey, Matthew Allen Schiffler, Maria-Jesus Blanco, Xiao-Peng Yu, Warshawsky Alan M, Matthew J. Fisher, Daniel R. Mudra
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 26:105-109
A novel series of EP4 antagonists, based on a quinoline scaffold, has been discovered. Medicinal chemistry efforts to optimize the potency of the initial hit are described. A highly potent compound in a clinically relevant human whole blood assay was
Autor:
Srinivasan Chandrasekhar, Bradley Condon, Matthew Allen Schiffler, Kuklish Steven Lee, Kim Euibong Jemes, Bryan H. Norman, John R. Rizzo, Jeremy Schulenburg York, Kristina M. Campanale, Stefan Jon Thibodeaux, Richard E. Rathmell, Michael J. Hickey, Christopher Groshong, Shobha N. Bhattachar, Norman Earle Hughes, Anita K. Harvey, John G. Luz, Stephen Antonysamy, Scott Alan Jones, Timothy Andrew Woods, Prashant V. Desai, Matthew J. Fisher, Xiao-Peng Yu, Thomas W. Seng
Publikováno v:
Journal of Medicinal Chemistry. 59:194-205
As part of a program aimed at the discovery of antinociceptive therapy for inflammatory conditions, a screening hit was found to inhibit microsomal prostaglandin E synthase-1 (mPGES-1) with an IC50 of 17.4 μM. Structural information was used to impr
Autor:
Bruce W. Shaw, Yuke Zhang, Kenneth C. Cassidy, Robert M. Christie, Prabhakar Kondaji Jadhav, Jim D. Durbin, Gary G. Deng, Matthew Allen Schiffler, Kostas Gavardinas, Richard A. Brier, Keyun Qing, Donald P. Matthews, Michael A. Staszak, William F. Matter, Yong Wang, Kim Euibong Jemes, D. Scott Coffey
Publikováno v:
ACS Medicinal Chemistry Letters. 5:1138-1142
Cathepsin S (Cat S) plays an important role in many pathological conditions, including abdominal aortic aneurysm (AAA). Inhibition of Cat S may provide a new treatment for AAA. To date, several classes of Cat S inhibitors have been reported, many of
Autor:
Srinivasan Chandrasekhar, Warshawsky Alan M, Xiao-Peng Yu, Xushan Wang, Kuklish Steven Lee, Anita K. Harvey, Jeremy Schulenburg York, Matthew J. Fisher, Matthew Allen Schiffler
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 25:3176-3178
EP4 is a prostaglandin E2 receptor that is a target for potential anti-nociceptive therapy. Described herein is a class of amphoteric EP4 antagonists which reverses PGE2-induced suppression of TNFα production in human whole blood. From this class, a
Autor:
Karen Gooding, Peter R. Manninen, James McGee, Matthew J. Fisher, Antonio Navarro, Warshawsky Alan M, Srinivasan Chandrasekhar, Daniel R. Mudra, Stephen Antonysamy, Adrian J. Fretland, Xiao-Peng Yu, Jeremy Schulenburg York, Jennifer M. Weller, Kuklish Steven Lee, Ashley V. Sloan, Shobha N. Bhattachar, Anita K. Harvey, Katherine M. Partridge, Steven James Quimby, Norman Earle Hughes, John G. Luz, Bryan H. Norman, Matthew Allen Schiffler
Publikováno v:
Bioorganicmedicinal chemistry letters. 27(6)
We describe a novel class of acidic mPGES-1 inhibitors with nanomolar enzymatic and human whole blood (HWB) potency. Rational design in conjunction with structure-based design led initially to the identification of anthranilic acid 5, an mPGES-1 inhi
Autor:
Shobha N. Bhattachar, Stephen Antonysamy, Warshawsky Alan M, Norman Earle Hughes, Matthew Allen Schiffler, Anita K. Harvey, Jeremy Schulenburg York, Antonio Navarro, John G. Luz, Bryan H. Norman, Katherine M. Partridge, Steven James Quimby, Xiao-Peng Yu, Karen Gooding, James McGee, Matthew J. Fisher, Kuklish Steven Lee, Srinivasan Chandrasekhar, Ashley V. Sloan, Peter R. Manninen, Adrian J. Fretland
Publikováno v:
Bioorganicmedicinal chemistry letters. 26(19)
Here we report on novel, potent 3,3-dimethyl substituted N-aryl piperidine inhibitors of microsomal prostaglandin E synthases-1(mPGES-1). Example 14 potently inhibited PGE2 synthesis in an ex vivo human whole blood (HWB) assay with an IC50 of 7 nM. I
Autor:
Stephanie L. Stout, Patrick C. May, Brian Morgan Watson, Pablo Garcia Losada, Valentine J. Klimkowski, Brian Michael Mathes, David E. Timm, Dustin J. Mergott, Scott A. Monk, Leonard L. Winneroski, Leonard N. Boggs, James P. Beck, James E. Audia, Matthew Allen Schiffler, Richard A. Brier, Anthony R. Borders, Jon A. Erickson, Robert D. Boyer, Kevin John Hudziak
Publikováno v:
Bioorganicmedicinal chemistry. 23(13)
The BACE1 enzyme is a key target for Alzheimer’s disease. During our BACE1 research efforts, fragment screening revealed that bicyclic thiazine 3 had low millimolar activity against BACE1. Analysis of the co-crystal structure of 3 suggested that po
Autor:
Anita K. Harvey, Srinivasan Chandrasekhar, C. Lin, Tatiana Natali Vetman, Xushan Wang, Matthew Allen Schiffler, Warshawsky Alan M, J.L. Oskins, Jeremy Schulenburg York, Mark Chambers, Alison M. Bendele, Matthew J. Fisher, Maria-Jesus Blanco, Xiao-Peng Yu, Kuklish Steven Lee
Publikováno v:
Pharmacology Research & Perspectives
Prostaglandin (PG) E2 is the key driver of inflammation associated with arthritic conditions. Inhibitors of PGE 2 production (NSAIDs and Coxibs) are used to treat these conditions, but carry significant side effect risks due to the inhibition of all